JNJ Johnson & Johnson Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

JNJ [NYSE]

Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	26.59	EPS (ttm)	5.58	Insider Own	0.10%	Shs Outstand	2.63B	Perf Week	-0.24%
Market Cap	387.53B	Forward P/E	16.40	EPS next Y	9.04	Insider Trans	-2.53%	Shs Float	2.63B	Perf Month	-0.68%
Income	14.89B	PEG	5.23	EPS next Q	1.96	Inst Own	70.70%	Short Float	0.48%	Perf Quarter	-1.46%
Sales	80.50B	P/S	4.81	EPS this Y	0.50%	Inst Trans	-0.11%	Short Ratio	1.85	Perf Half Y	-1.26%
Book/sh	23.92	P/B	6.20	EPS next Y	14.91%	ROA	9.70%	Target Price	166.06	Perf Year	13.56%
Cash/sh	7.32	P/C	20.25	EPS next 5Y	5.08%	ROE	25.10%	52W Range	109.16 - 157.00	Perf YTD	1.62%
Dividend	4.04	P/FCF	53.23	EPS past 5Y	-0.20%	ROI	17.30%	52W High	-5.58%	Beta	0.68
Dividend %	2.73%	Quick Ratio	1.00	Sales past 5Y	2.00%	Gross Margin	65.80%	52W Low	35.80%	ATR	2.25
Employees	132200	Current Ratio	1.20	Sales Q/Q	-10.80%	Oper. Margin	20.30%	RSI (14)	53.73	Volatility	1.40% 1.37%
Optionable	Yes	Debt/Eq	0.48	EPS Q/Q	-34.70%	Profit Margin	18.90%	Rel Volume	0.62	Prev Close	148.00
Shortable	Yes	LT Debt/Eq	0.40	Earnings	Jul 16 BMO	Payout	66.90%	Avg Volume	6.78M	Price	148.24
Recom	1.90	SMA20	0.12%	SMA50	2.02%	SMA200	3.70%	Volume	4,178,459	Change	0.16%

Apr-28-20

Downgrade

UBS

Buy → Neutral

$163 → $160

Apr-22-20

Upgrade

BofA/Merrill

Neutral → Buy

$150 → $175

Mar-05-20

Initiated

Citigroup

Buy

$163

Dec-19-19

Upgrade

Barclays

Equal Weight → Overweight

$173

Dec-17-19

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$145 → $170

Nov-20-19

Initiated

Cantor Fitzgerald

Overweight

$160

Oct-16-19

Upgrade

Atlantic Equities

Underweight → Neutral

Oct-11-19

Upgrade

Bernstein

Mkt Perform → Outperform

$155

Jul-12-19

Resumed

Credit Suisse

Outperform

$156

May-28-19

Initiated

Goldman

Buy

Jan-23-19

Reiterated

Barclays

Equal Weight

$137 → $135

Jul-12-18

Upgrade

Goldman

Sell → Neutral

Jun-27-18

Initiated

Bernstein

Mkt Perform

$129

Apr-23-18

Reiterated

Citigroup

Neutral

$146 → $134

Apr-18-18

Reiterated

Stifel

Hold

$145 → $135

Jan-24-18

Reiterated

Stifel

Hold

$142 → $145

Jan-12-18

Reiterated

Wells Fargo

Outperform

$155 → $160

Jan-02-18

Downgrade

JP Morgan

Overweight → Neutral

Oct-18-17

Reiterated

Stifel

Hold

$140 → $142

Oct-18-17

Reiterated

RBC Capital Mkts

Outperform

$144 → $147

Aug-14-20 04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
12:00PM	FOCUS-Vaccine makers including Moderna must hit U.S. timing goals for full payments Reuters
10:04AM	Novavax and Johnson & Johnson to Supply U.K. With Covid-19 Vaccines TheStreet.com
07:16AM	U.K. strikes two Covid-19 vaccine deals for 90 million doses MarketWatch
02:30AM	Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax deals Reuters
02:10AM	UK buys potential COVID-19 vaccines from J&J and Novavax Reuters
Aug-13-20 06:48PM	Why Big Brand Stocks Are Dying GuruFocus.com
04:25PM	Johnson & Johnson stock underperforms Thursday when compared to competitors MarketWatch
04:24PM	Robert Olstein's Top 2nd-Quarter Trades GuruFocus.com
02:44PM	EU Secures 200M Doses Of Johnson & Johnsons Covid-19 Vaccine Candidate SmarterAnalyst
02:10PM	Johnson & Johnson, EU Complete Exploratory Talks for Vaccine TheStreet.com
12:18PM	EU to enter contract talks with J&J over 200 million doses of potential COVID-19 vaccine Reuters
12:06PM	EU wraps up talks with Johnson & Johnson to buy potential COVID-19 vaccine Reuters
09:38AM	2 Large-Cap Stocks You Can Buy Right Now Motley Fool
09:09AM	Is Johnson & Johnson a Great Dividend Stock? Motley Fool
08:17AM	Intuitives $68 Billion Rally Has Bears Warning Heyday Is Over Bloomberg
07:58AM	Indian drugmaker Biological E. to make substance used in J&J's potential COVID-19 vaccine Reuters
07:36AM	2 Top Stocks for Retirees Motley Fool
Aug-12-20 04:25PM	Johnson & Johnson stock rises Wednesday, outperforms market MarketWatch
Aug-11-20 04:25PM	Johnson & Johnson stock falls Tuesday, still outperforms market MarketWatch
12:19PM	Coronavirus update: Russia approves world's first vaccine amid skepticism, Trump weighs travel ban on Americans Yahoo Finance
10:59AM	Mexico to trial China, U.S. COVID-19 vaccines, may produce some Reuters
10:53AM	J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trials Reuters
10:48AM	J&J eyes 1 bln doses of potential COVID-19 shot in 2021, weighs challenge trials Reuters
08:56AM	Mexico to conduct late-stage trials for China, US COVID-19 vaccines Reuters
Aug-10-20 07:03PM	Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September Reuters
04:25PM	Johnson & Johnson stock underperforms Monday when compared to competitors MarketWatch
12:46PM	Warren Buffett: We Sell When the Fundamentals Have Changed GuruFocus.com
Aug-07-20 04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
12:27PM	Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises Yahoo Finance
Aug-06-20 06:24PM	Yacktman Asset Management's Top 5 Sells of the 2nd Quarter GuruFocus.com
04:31PM	We need to make sure that the science and safety is there so people can trust the vaccine: doctor Yahoo Finance Video
04:25PM	Johnson & Johnson stock falls Thursday, underperforms market MarketWatch
03:00PM	Dow Jones Rises On Jobless Claims; Two Leaderboard Stocks In Buy Zones Investor's Business Daily
02:22PM	Return On Capital Employed Overview: Johnson & Johnson Benzinga
02:17PM	MediPharm Labs Appoints Former Janssen Exec To Board Benzinga
02:04PM	Buy Moderna Stock as the COVID-19 Vaccine Race Heats Up, Says 5-Star Analyst TipRanks
12:31PM	Dow Jones Leads As Apple Eyes New High; Stocks Mixed After Jobless Claims Data Investor's Business Daily
09:53AM	Trump says coronavirus vaccine possible before Nov. 3 Reuters
Aug-05-20 09:52PM	U.S. FDA approves GlaxoSmithKline's blood cancer drug Reuters
09:25PM	PRESS DIGEST- Financial Times - Aug. 6 Reuters
07:08PM	Asian Stocks Down Over Mixed U.S. Economic Data and Stall in Stimulus Measures Investing.com
07:00PM	4 High-Quality S&P Stocks With High 6-Month Total Returns GuruFocus.com
04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
04:16PM	Nasdaq at Record - Stocks Up on Disney Report, J&J Vaccine Pact TheStreet.com
04:14PM	Novavax Stock Spirals To Record High On Positive Coronavirus Vaccine Data Investor's Business Daily
03:19PM	Dow Jones Rises After Disney Earnings Beat Investor's Business Daily
01:35PM	Dow Jones Up 700 Points This Week; Nasdaq Hits Another New High Investor's Business Daily
12:11PM	Dow Jones Jumps 350 Points On Coronavirus Vaccine News, Disney Earnings; Novavax Soars 18%, Square Surges 14% Investor's Business Daily
12:00PM	US STOCKS-Wall St gains on Disney's surprise profit, fiscal aid hopes Reuters
11:59AM	Why Moderna Stock Is Slipping Today Motley Fool
10:46AM	US STOCKS-Wall St rises on Disney's surprise profit, services sector data Reuters
10:39AM	Johnson & Johnson Clinches Coronavirus Vaccine Deal With US Government: $1B, 100M Doses Benzinga
10:20AM	Johnson & Johnson Signs $1 Billion U.S. Government Deal for Vaccine. Its Stock Is Rising. Barrons.com
09:32AM	U.S. to pay over $1 billion for 100 million doses of J&J's potential COVID-19 vaccine Reuters
09:32AM	U.S. to pay $1 billion for 100 million doses of J&J's COVID-19 vaccine candidate Reuters
09:31AM	Johnson & Johnson Gains After Reaching 100 Million Dose Agreement With US Government For COVID-19 Vaccine TheStreet.com
08:56AM	U.S. to pay over $1 bln for 100 mln doses of J&J's potential COVID-19 vaccine Reuters
08:38AM	J&J to receive $1 billion in U.S. funding to make 100 million doses of its COVID-19 vaccine MarketWatch
08:30AM	Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine PR Newswire
05:33AM	Dow Opens Higher on Economic Relief Progress, U.S.-China Talks Investing.com
Aug-04-20 10:22PM	Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions Moody's
04:25PM	Johnson & Johnson stock falls Tuesday, underperforms market MarketWatch
02:22PM	Why Intuitive Surgical Stock Surged 20% in July Motley Fool
09:56AM	Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions Moody's
09:21AM	Vaccine Confronts Humanity With Next Moral Test Bloomberg
07:00AM	100-Year-Old Antitrust Laws Are No Match for Big Tech Bloomberg
Aug-03-20 04:25PM	Johnson & Johnson stock rises Monday, outperforms market MarketWatch
11:19AM	5 Top Dividend Kings to Buy and Hold Forever Motley Fool
Aug-02-20 06:00PM	Big Pharma Shouldnt Be Too Greedy Bloomberg
04:31PM	The Market Continues to Undervalue AbbVie GuruFocus.com
11:25AM	2 Stocks to Bankroll Your Retirement Motley Fool
09:07AM	2 Dividend Stocks You Can Safely Hold for Decades Motley Fool
Jul-31-20 04:35PM	We need a national plan to bring us down to an agreed about level: doctor Yahoo Finance Video
04:25PM	Johnson & Johnson stock falls Friday, underperforms market MarketWatch
03:26PM	Emergent Biosolutions CEO: 'hyperfocused' on manufacturing COVID-19 vaccine candidates Yahoo Finance Video
01:41PM	Coronavirus update: Fauci, CDC face Congress as US coronavirus cases spiral higher Yahoo Finance
11:47AM	U.S. pledges $2.1B to Sanofi and GSK for 100 million doses of its COVID-19 vaccine Yahoo Finance Video
10:36AM	RPT-Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
09:25AM	Sanofi, GSK get $2.1B in government money for coronavirus vaccine Yahoo Finance Video
09:04AM	Here's How to Build the Safest But Most Promising Coronavirus Portfolio Motley Fool
07:45AM	The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche Benzinga
07:18AM	Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
07:00AM	Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
06:00AM	How Bill Gates would treat COVID-19 if he were President of the United States Yahoo Finance Video
Jul-30-20 07:46PM	10 Biggest Health Care Companies Investopedia
05:39PM	Johnson & Johnson's Coronavirus Vaccine Candidate Efficacious in Pre-Clinical Studies; Human Testing Has Begun Motley Fool
04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
04:22PM	Pfizer Covid-19 Vaccine Sales Could Hit $15 Billion GuruFocus.com
04:03PM	U.S. Cases Up 1.9%; Californias 2nd-Deadliest Day: Virus Update Bloomberg
01:37PM	US STOCKS-S&P 500, Dow slip after grim data; Trump suggests election delay Reuters
12:01PM	J&J starts human trials of COVID-19 vaccine Reuters Videos
11:50AM	US STOCKS-Wall St falls after grim data; Trump suggests election delay Reuters
10:47AM	US STOCKS-Wall St falls after historic GDP slump, Trump suggests election delay Reuters
09:31AM	Johnson & Johnson Sees Solid Results From COVID-19 Vaccine Trial; Launches Human Study in U.S. and Europe TheStreet.com
09:18AM	Johnson & Johnson Begins Trial of Covid-19 Vaccine in One-Dose Regimen Barrons.com
08:58AM	Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate SmarterAnalyst
08:51AM	US STOCKS-Futures sink as data shows historic slump Reuters
07:00AM	Influencers with Andy Serwer: Bill Gates Yahoo Finance Video
07:00AM	Bill Gates: We should be able 'to manufacture a lot of vaccines in 2021' Yahoo Finance Video

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has collaboration agreements with Morphic Therapeutic; and Emergent BioSolutions, Inc. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McEvoy Ashley	EVP, WW Chair, Medical Devices	Jul 28	Sale	147.47	29,000	4,276,630	21,682	Jul 28 06:43 PM
JOHNSON & JOHNSON	10% Owner	Jun 30	Buy	17.00	725,000	12,325,000	3,670,516	Jul 02 04:58 PM
PEREZ WILLIAM D	Director	Mar 13	Buy	127.69	500	63,843	16,030	Mar 17 04:24 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Option Exercise	90.44	19,224	1,738,619	75,039	Feb 25 04:23 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Sale	147.96	39,224	5,803,583	35,815	Feb 25 04:23 PM
Ullmann Michael H	Exec VP, General Counsel	Feb 13	Option Exercise	0.00	20,326	0	152,697	Feb 18 05:03 PM
Wolk Joseph J	Exec VP, CFO	Feb 13	Option Exercise	0.00	7,080	0	21,387	Feb 18 05:03 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Feb 13	Option Exercise	0.00	15,809	0	65,532	Feb 18 05:03 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13	Option Exercise	0.00	22,231	0	110,559	Feb 18 05:03 PM
Decker Robert J	Controller, CAO	Feb 13	Option Exercise	0.00	1,499	0	13,946	Feb 18 05:03 PM
Duato Joaquin	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	105,668	0	220,373	Feb 18 05:03 PM
Gorsky Alex	Chairman, CEO	Feb 13	Option Exercise	0.00	107,016	0	496,472	Feb 18 05:03 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 13	Option Exercise	0.00	13,747	0	56,496	Feb 18 05:03 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 13	Option Exercise	0.00	3,692	0	57,259	Feb 18 05:03 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Feb 13	Option Exercise	0.00	11,836	0	61,219	Feb 18 05:03 PM
Stoffels Paulus	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	39,381	0	270,900	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 13	Option Exercise	0.00	16,084	0	115,813	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 03	Option Exercise	0.00	48,312	0	123,450	Feb 04 07:31 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 03	Option Exercise	0.00	38,650	0	58,154	Feb 04 07:31 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Option Exercise	62.62	58,128	3,639,975	107,511	Feb 03 06:28 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Sale	149.39	58,128	8,683,568	49,383	Feb 03 06:28 PM
Joly Hubert	Director	Dec 13	Buy	141.28	5,000	706,399	5,000	Dec 16 04:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Option Exercise	62.62	2,017	126,305	51,736	Dec 16 05:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Sale	141.07	2,017	284,538	49,719	Dec 16 05:40 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience